77 results on '"BARTOLETTI, Riccardo"'
Search Results
2. Evaluation of Clinical Research on Novel Multiport Robotic Platforms for Urological Surgery According to the IDEAL Framework: A Systematic Review of the Literature
3. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines
4. Genitourinary Tuberculosis: A Brief Manual for Urologists on Diagnosis and Treatment from the European Association of Urology Urological Infections Panel
5. An analytical approach based on excitation-emission fluorescence spectroscopy and chemometrics for the screening of prostate cancer through urine analysis: A proof–of–concept study
6. Prospective Cross-Sectional Evaluation of Penile Helicine Circulation by Power Doppler During Dynamic Ultrasound in Veno-Occlusive Erectile Dysfunction
7. Segmental Ureterectomy Versus Radical Nephroureterectomy in Older Patients Treated for Upper Tract Urothelial Carcinoma
8. A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance
9. Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?
10. Management of Urosepsis in 2018
11. Management of Urethritis: Is It Still the Time for Empirical Antibiotic Treatments?
12. Update on Strategies to Reduce Infectious Complications After Prostate Biopsy
13. Is Preoperative Assessment and Treatment of Asymptomatic Bacteriuria Necessary for Reducing the Risk of Postoperative Symptomatic Urinary Tract Infections After Urologic Surgical Procedures?
14. Management of the Urologic Sepsis Syndrome
15. Treatment of Urinary Tract Infections and Antibiotic Stewardship
16. Chlamydia trachomatis Infection Is Related to Premature Ejaculation in Chronic Prostatitis Patients: Results from a Cross‐Sectional Study
17. Concordance and Clinical Significance of Uncommon Variants of Bladder Urothelial Carcinoma in Transurethral Resection and Radical Cystectomy Specimens
18. Dapoxetine Treatment in Patients With Lifelong Premature Ejaculation: The Reasons of a “Waterloo”
19. WCN24-2073 Xanthine Incrustation in JJ Stents: a Rare Complication of Urate-Lowering Therapy in Lesch-Nyhan Syndrome with Kidney Stones
20. Genital Chlamydia trachomatis Infection is Related to Poor Sexual Quality of Life in Young Sexually Active Women
21. Clinical Importance of Lymph Node Density in Predicting Outcome of Prostate Cancer Patients
22. Chlamydia trachomatis Infection Is Related to Poor Semen Quality in Young Prostatitis Patients
23. Loss of Heterozygosis on IFN-α Locus is a Prognostic Indicator of Bacillus Calmette-Guerin Response for Nonmuscle Invasive Bladder Cancer
24. Prognostic Role of Loss of Heterozygosity on Chromosome 18 in Patients With Low-Risk Nonmuscle-Invasive Bladder Cancer: Results from a Prospective Study
25. Regular Moderate Intake of Red Wine Is Linked to a Better Women's Sexual Health
26. Prostate Growth and Prevalence of Prostate Diseases in Early Onset Spinal Cord Injuries
27. ORIGINAL RESEARCH—PEYRONIE'S DISEASE: Use of Penile Extender Device in the Treatment of Penile Curvature as a Result of Peyronie's Disease. Results of a Phase II Prospective Study
28. Serenoa repens associated with Urtica dioica (ProstaMEV ®) and curcumin and quercitin (FlogMEV ®) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study
29. The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer
30. Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study
31. Finasteride 5 mg and Sexual Side Effects: How Many of these are Related to a Nocebo Phenomenon?
32. Interleukin 8 and Anti-Chlamydia trachomatis Mucosal IgA as Urogenital Immunologic Markers in Patients with C. trachomatis Prostatic Infection
33. Prevalence, Incidence Estimation, Risk Factors and Characterization of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Urological Hospital Outpatients in Italy: Results of a Multicenter Case-Control Observational Study
34. Interleukin-6/10 Ratio as a Prognostic Marker of Recurrence in Patients With Intermediate Risk Urothelial Bladder Carcinoma
35. New Insights Into the Pathogenesis of Penile Shortening After Radical Prostatectomy and the Role of Postoperative Sexual Function
36. Physical Activity of Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome Not Satisfied With Conventional Treatments—Could it Represent a Valid Option? The Physical Activity and Male Pelvic Pain Trial: A Double-Blind, Randomized Study
37. Loss of P16 Expression and Chromosome 9p21 LOH in Predicting Outcome of Patients Affected by Superficial Bladder Cancer
38. Alfuzosin (10 mg) Does Not Affect Blood Pressure in Young Healthy Men
39. Multiplex Polymerase Chain Reaction for Microsatellite Analysis of Urine Sediment Cells: A Rapid and Inexpensive Method for Diagnosing and Monitoring Superficial Transitional Bladder Cell Carcinoma
40. The Italian Version of the National Institutes of Health Chronic Prostatitis Symptom Index
41. Intravesical gemcitabine therapy for superficial transitional cell carcinoma: Results of a Phase II prospective multicenter study
42. Perineal and robot-assisted vesico-urethral reconstruction for anastomotic strictures after RP
43. Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis by the European Association of Urology Urological Infection Guidelines Panel
44. EDITORIAL COMMENT
45. European Association of Urology Position Paper on the Prevention of Infectious Complications Following Prostate Biopsy
46. The Global Prevalence of Infections in Urology (GPUI) Study: A Worldwide Surveillance Study in Urology Patients
47. How to Use Antimicrobial Prophylaxis in Urological Procedures
48. PD48-07 RECURRENCE AND PROGRESSION ACCORDING TO STAGE AT RE-TUR IN T1G3 BLADDER CANCER PATIENTS TREATED WITH BCG: NOT AS BAD AS PREVIOUSLY THOUGHT
49. PD48-03 RISK FACTORS FOR RESIDUAL DISEASE AT RE-TUR IN T1G3 BLADDER CANCER
50. Editorial Comment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.